Robert A. Harrington

Durham University

2

h-index

2

Publications

972

Citations

Publications

2 shown

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Christopher P. Cannon , Steen Husted , Robert A. Harrington +4 more

2007 Journal of the American College of Ca... 489 citations

Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

Robert F. Storey , Steen Husted , Robert A. Harrington +8 more

2007 Journal of the American College of Ca... 483 citations

Frequent Co-Authors

Christopher P. Cannon

Brigham and Women's Hospital

Steen Husted

Aarhus University Hospital

Benjamin M. Scirica

Brigham and Women's Hospital

Håkan Emanuelsson

AstraZeneca (Sweden)

Gary Peters

AstraZeneca (United States)

Robert F. Storey

University of Sheffield

Researcher Info

h-index: 2
Publications: 2
Citations: 972
Institution: Durham University

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.